The documented role of pharmacogenetic: in the identification and administration of new medications for treating drug abuse

Autor: Cv, Grudzinskas, Raymond L. Woosley, Tj, Payte, Collins J, Moody DE, Rf, Tyndale, Em, Sellers

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::79735a84a03d0bf97f9c5756ed88c61d
https://pubmed.ncbi.nlm.nih.gov/9066815

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.

Autor: Robinson KM; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA., Eum S; Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, USA., Desta Z; Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Tyndale RF; Department of Pharmacology & Toxicology, and Psychiatry, The Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Crist RC; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Haidar CE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Myers AL; Department of Diagnostic & Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA., Samer CF; Department of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland., Somogyi AA; Discipline of Pharmacology, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia., Zubiaur P; Department of Clinical Pharmacology, Hospital Universitario de la Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain., Iwuchukwu OF; Department of Pharmaceutical Sciences, School of Pharmacy and Health Sciences, Farleigh Dickinson University, Florham Park, New Jersey, USA., Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Caudle KE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Donnelly RS; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA., Kharasch ED; Department of Anesthesiology, Duke University School of Medicine | Bermaride LLC, Durham, North Carolina, USA.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 932-938. Date of Electronic Publication: 2024 Jun 11.

Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers.

Autor: Pouget JG; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Giratallah H; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada., Langlois AWR; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada., El-Boraie A; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada., Lerman C; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA., Knight J; Data Science Institute and Medical School, Lancaster University, Lancaster, UK., Cox LS; Department of Population Health, University of Kansas School of Medicine, Kansas City, KS, USA., Nollen NL; Department of Population Health, University of Kansas School of Medicine, Kansas City, KS, USA., Ahluwalia JS; Departments of Behavioral and Social Sciences and Medicine, Brown University, Providence, RI, USA., Benner C; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland., Chenoweth MJ; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada., Tyndale RF; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. r.tyndale@utoronto.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. r.tyndale@utoronto.ca.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada. r.tyndale@utoronto.ca.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2024 Aug 31. Date of Electronic Publication: 2024 Aug 31.

Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline.

Autor: Chenoweth MJ; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Kim YJ; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Nollen NL; Department of Population Health, University of Kansas School of Medicine, Kansas City, Kansas, USA., Hawk LW Jr; Department of Psychology, University at Buffalo, Buffalo, New York, USA., Mahoney MC; Department of Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Lerman C; USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Knight J; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Data Science Institute, Lancaster University Medical School, Lancaster, UK., Tyndale RF; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1277-1281. Date of Electronic Publication: 2024 Feb 19.

Behavioral and Pharmacokinetic Assessment of Nicotine e-Cigarette Inhalation in Female Rats.

Autor: Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Mihalkovic A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Novalen M; Center for Addiction and Mental Health and Departments of Pharmacology and Toxicology, and Psychiatry, University of Toronto, Toronto, Ontario, Canada., Hammond N; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Eiden R; Department of Psychology, Social Science Research Institute, Pennsylvania State University, University Park, PA, USA., Khokhar JY; Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Tyndale RF; Center for Addiction and Mental Health and Departments of Pharmacology and Toxicology, and Psychiatry, University of Toronto, Toronto, Ontario, Canada., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA.

Publikováno v: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco [Nicotine Tob Res] 2024 May 22; Vol. 26 (6), pp. 724-732.